Polyion Complex Comprising PHD2 Expression Inhibiting Substance

Disclosed is a safer and more sustainable gene delivery system or the like, which is effective for treatment of ischemic diseases and the like. Specifically disclosed is a pharmaceutical composition which contains, as an active ingredient, a polyanionic substance that inhibits the expression of PHD2, and which contains a polyion complex of the polyanionic substance and a polycationically charged polymer.

Patents:
JP 2,011,026,219   [MORE INFO]

Inventor(s): KATAOKA KAZUNORI [JP]; WU SHOURONG [JP]; NISHIYAMA NOBUHIRO [JP]; ITAKA KEIJI [JP]; KOYAMA HIROYUKI [JP]; HASHIMOTO TAKUYA [JP];

Type of Offer: Sale



« More Material Science Patents
« More Medical Patents

---